Apnea Sciences Corporation
Letter data
- Company
- Apnea Sciences Corporation
- Recipient
- James Fallon | CEO | Apnea Sciences Corporation | 27121 Aliso Creek Rd | Ste 140 | Aliso Viejo | , | CA | 92656-5308 | United States
- Issue date
- 2019-04-29
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 392712
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Apnea Sciences Corporation
MARCS-CMS 392712 —
April 29, 2019
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
United Parcel Service
Product:
Medical Devices
Recipient:
Recipient Name
James Fallon
Recipient Title
CEO
Apnea Sciences Corporation
27121 Aliso Creek Rd
Ste 140
Aliso Viejo
,
CA
92656-5308
United States
Issuing Office:
Center for Devices and Radiological Health
19701 Fairchild Road
Los Angeles
,
CA
92612
United States
Dear Mr. Fallon:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter (WL #37-13), dated 05/09/2013. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Jeffrey Wooley
(Acting) Compliance Branch Director
FDA/Office of Regulatory Affairs
Office of Medical Device and Radiological Health Operations
Division 3/West Compliance Branch
Content current as of:
05/09/2019
Regulated Product(s)
Medical Devices